Exact Mass: 401.1627

Exact Mass Matches: 401.1627

Found 95 metabolites which its exact mass value is equals to given mass value 401.1627, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-(1-carboxy-2-hydroxypropyl)-4-{[5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-3-methyl-3,4-dihydro-2h-pyrrole-5-carboxylic acid

2-(1-Carboxy-2-hydroxypropyl)-4-{[5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulphanyl}-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid

C17H27N3O6S (401.162)

Ghrelin agonist HM01

3-[1-(2,3-dichloro-4-methoxyphenyl)ethyl]-1-methyl-1-(1,3,3-trimethylpiperidin-4-yl)urea

C19H29Cl2N3O2 (401.1637)

Setoperone

6-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-7-methyl-2H,3H,5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one

C21H24FN3O2S (401.1573)

Meropenem Metabolite (2H-Pyrrole-2-acetic acid, 5-carboxy-4-[[(3S,5S)-5-[(dimethylamino)carbonyl]-3-

C17H27N3O6S (401.162)

Asp Gly Asn Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C15H23N5O8 (401.1547)

Asp Gly Pro Asn

(3S)-3-amino-3-({2-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-2-oxoethyl}carbamoyl)propanoic acid

C15H23N5O8 (401.1547)

Asp Asn Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]acetyl}pyrrolidine-2-carboxylic acid

C15H23N5O8 (401.1547)

Asp Asn Pro Gly

(3S)-3-amino-3-{[(2S)-3-carbamoyl-1-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}propanoic acid

C15H23N5O8 (401.1547)

Asp Pro Gly Asn

(3S)-3-amino-4-[(2S)-2-[({[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}methyl)carbamoyl]pyrrolidin-1-yl]-4-oxobutanoic acid

C15H23N5O8 (401.1547)

Asp Pro Asn Gly

(3S)-3-amino-4-[(2S)-2-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C15H23N5O8 (401.1547)

Gly Asp Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C15H23N5O8 (401.1547)

Gly Asp Pro Asn

(3S)-3-(2-aminoacetamido)-4-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C15H23N5O8 (401.1547)

Gly Asn Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C15H23N5O8 (401.1547)

Gly Asn Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C15H23N5O8 (401.1547)

Gly Pro Asp Asn

(3S)-3-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}propanoic acid

C15H23N5O8 (401.1547)

Gly Pro Asn Asp

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]butanedioic acid

C15H23N5O8 (401.1547)

Tyr Tyr Gly

C20H23N3O6 (401.1587)

Asn Asp Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]acetyl}pyrrolidine-2-carboxylic acid

C15H23N5O8 (401.1547)

Asn Asp Pro Gly

(3S)-3-[(2S)-2-amino-3-carbamoylpropanamido]-4-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-4-oxobutanoic acid

C15H23N5O8 (401.1547)

Asn Gly Asp Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C15H23N5O8 (401.1547)

Asn Gly Pro Asp

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetyl}pyrrolidin-2-yl]formamido}butanedioic acid

C15H23N5O8 (401.1547)

Asn Pro Asp Gly

(3S)-3-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-[(carboxymethyl)carbamoyl]propanoic acid

C15H23N5O8 (401.1547)

Asn Pro Gly Asp

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetamido)butanedioic acid

C15H23N5O8 (401.1547)

Pro Asp Gly Asn

(3S)-3-[({[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}methyl)carbamoyl]-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C15H23N5O8 (401.1547)

Pro Asp Asn Gly

(3S)-3-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C15H23N5O8 (401.1547)

Pro Gly Asp Asn

(3S)-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-3-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanoic acid

C15H23N5O8 (401.1547)

Pro Gly Asn Asp

(2S)-2-[(2S)-3-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]butanedioic acid

C15H23N5O8 (401.1547)

Pro Asn Asp Gly

(3S)-3-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C15H23N5O8 (401.1547)

Pro Asn Gly Asp

(2S)-2-{2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}butanedioic acid

C15H23N5O8 (401.1547)

Gly Tyr Tyr

C20H23N3O6 (401.1587)

Terbutaline-1-glucuronide

C18H27NO9 (401.1686)

Lys-Phe-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)-3-phenylpropanoic acid

C20H23N3O6 (401.1587)

Phe-Lys-OH

(S)-7-amino-2-(3-(benzyloxy)-4-nitrobenzamido)heptanoic acid

C20H23N3O6 (401.1587)

JWH 369

C26H24ClNO (401.1546)

Fmoc-N-methyl--D-phenylalanine

C25H23NO4 (401.1627)

3-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(4-methylphenyl)propanoic acid

C25H23NO4 (401.1627)

N-Fmoc-erythro-DL-beta-methylphenylalanine

C25H23NO4 (401.1627)

fmoc-d-homophenylalanine

C25H23NO4 (401.1627)

Boc-Trp-OSu

C20H23N3O6 (401.1587)

Fmoc-L-2-Methylphe

C25H23NO4 (401.1627)

Fmoc-D-beta-homophenylalanine

C25H23NO4 (401.1627)

fmoc-(r)-3-amino-3-(2-methyl-phenyl)-propionic acid

C25H23NO4 (401.1627)

fmoc-(r)-3-amino-3-(3-methyl-phenyl)-propionic acid

C25H23NO4 (401.1627)

Fmoc-N-Me-Phe-OH

C25H23NO4 (401.1627)

FMOC-D-3-METHYLPHENYLALANINE

C25H23NO4 (401.1627)

Fmoc-2-methyl-D-phenylalanine

C25H23NO4 (401.1627)

Fmoc-3-methyl-L-phenylalanine

C25H23NO4 (401.1627)

Fmoc-D-phe(4-me)-OH

C25H23NO4 (401.1627)

Fmoc-D-4-Methoxy-Phe-OH

C25H23NO4 (401.1627)

Fmoc-D-HomoPhe-OH

C25H23NO4 (401.1627)

Fmoc-Homo-Phe-OH

C25H23NO4 (401.1627)

Fmoc-L-beta-homophenylalanine

C25H23NO4 (401.1627)

Setoperone

5H-THIAZOLO[3,2A]PYRIMIDIN-5-ONE, 6-[2-[4-(4-FLUOROBENZOYL)-1-PIPERIDINYL]ETHYL]-2,3-DIHYDRO-7-METHYL-

C21H24FN3O2S (401.1573)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

Fmoc-4-(4-aminophenyl)butanoic acid

C25H23NO4 (401.1627)

fmoc-(s)-3-amino-3-(3-methyl-phenyl)-propionic acid

C25H23NO4 (401.1627)

Fmoc-Phe(4-Me)-OH

C25H23NO4 (401.1627)

3-(9 H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-4-PHENYL-BUTYRIC ACID

C25H23NO4 (401.1627)

TNP 470

O-(chloroacetylcarbamoyl)fumagillol

C19H28ClNO6 (401.1605)

C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C2143 - Endothelial Cell Inhibitor D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D006133 - Growth Substances > D006131 - Growth Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

(R)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-2-BENZYLPROPANOIC ACID

C25H23NO4 (401.1627)

(4R,5S)-5-[(1S,2R)-1-Carboxy-2-hydroxypropyl]-3-{[(3S,5S)-5-(dimethylcarbamoyl)-3-pyrrolidinyl]sulfanyl}-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid

C17H27N3O6S (401.162)

FMoc-alpha-Methyl-L-phenylalanine

C25H23NO4 (401.1627)

Cathepsin Inhibitor 1

C20H24ClN5O2 (401.1618)

fmoc-(s)-3-amino-3-(4-methyl-phenyl)-propionic acid

C25H23NO4 (401.1627)

fmoc-(s)-3-amino-3-(2-methyl-phenyl)-propionic acid

C25H23NO4 (401.1627)

dl-n-fmoc-2-methylphenylalanine

C25H23NO4 (401.1627)

Fmoc-L-HomoTyr(tBu)-OH

C25H23NO4 (401.1627)

fmoc-(r)-3-amino-3-(4-methyl-phenyl)-propionic acid

C25H23NO4 (401.1627)

L-glutamyl-L-glutamic acid 2-naphthylamide

C20H23N3O6 (401.1587)

L-Tyrosine, glycyl-L-tyrosyl-

C20H23N3O6 (401.1587)

L-Tyrosylglycyl-L-tyrosine

C20H23N3O6 (401.1587)

[5-(2-Chlorophenyl)-1-pentylpyrrol-3-yl]-naphthalen-1-ylmethanone

C26H24ClNO (401.1546)

N-[3-(6-Phenyl-3H-imidazo[4,5-b]pyridine-2-yl)-4-fluorophenyl]pyrrolidine-1-carboxamide

C23H20FN5O (401.1652)

4-fluoro-N-[4-[[[2-(methylamino)-4-quinazolinyl]amino]methyl]phenyl]benzamide

C23H20FN5O (401.1652)

Cinacalcet carbamate

C23H22F3NO2 (401.1603)

Tyr-Tyr-Gly

C20H23N3O6 (401.1587)

ethyl N-[4-[(4,4-diethyl-2,5-dioxoimidazolidin-1-yl)methyl]-2-oxochromen-7-yl]carbamate

C20H23N3O6 (401.1587)

(1R,5S)-7-[4-[(E)-prop-1-enyl]phenyl]-N-[4-(trifluoromethyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

C22H22F3N3O (401.1715)

[(3aR,4R,9bR)-8-(2-phenylethynyl)-1-(2-thiazolylmethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol

C24H23N3OS (401.1562)

[(3aS,4S,9bS)-8-(2-phenylethynyl)-1-(2-thiazolylmethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol

C24H23N3OS (401.1562)

(1S,5R)-7-[4-[(E)-prop-1-enyl]phenyl]-N-[4-(trifluoromethyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

C22H22F3N3O (401.1715)

Gly-Tyr-Tyr

C20H23N3O6 (401.1587)

Tyr-Gly-Tyr

C20H23N3O6 (401.1587)

N-Fmoc-N-benzyl-L-alanine

C25H23NO4 (401.1627)

N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-benzyl-L-alanine is an alanine derivative[1].

SHEN26

C19H23N5O5 (401.1699)

SHEN26 (ATY014) is a potent and orally active RdRp inhibitor, with an IC50 for SARS-CoV-2 is 1.36 μM. SHEN26 is a 5’-cyclohexanecarboxylate derivative of GS-441524 (HY-103586). SHEN26 inhibits viral nucleic acid synthesis to achieve antiviral effects. SHEN26 can be used for the research of coronavirus disease 2019 (COVID-19)[1][2].

(3r,4s,5s,6r)-5-methoxy-4-[(3r)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl n-(2-chloro-1-hydroxyethylidene)carbamate

C19H28ClNO6 (401.1605)

5-methoxy-4-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl n-(2-chloro-1-hydroxyethylidene)carbamate

C19H28ClNO6 (401.1605)